B
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Price:
3.01
USD
-57.3%
Market Closed
Market Cap:
$58m
Relative Value
There is not enough data to reliably calculate the relative value of BLAC.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BLAC
Relative Value
Base Case
Not Available
Multiples Across Competitors
BLAC Competitors Multiples
Bellevue Life Sciences Acquisition Corp Competitors
Bellevue Life Sciences Acquisition Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
B
|
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
|
58m USD | 0 | -122.2 | -26.7 | -26.7 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
209B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
104.1B ZAR | 6.2 | 9.7 | 15.4 | 15.5 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
34.4B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
43.4B USD | 0 | 0 | 0 | 0 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.5B USD | 15.8 | -2 092.9 | -1 040.3 | -471.9 | |
| US |
|
Coupang Inc
F:788
|
26.5B EUR | 0.9 | 80 | 20.3 | 33.4 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
30.8B ZAR | 5.8 | 7.2 | 18 | 18 | |
| ID |
|
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
528.6T IDR | 44.3 | -122.3 | 2 611.7 | 2 611.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
